hemoshear.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: *
Meta Tags
Title HemoShear - Discovering New Treatments For Metabolic Disorders | HemoShear
Description New Insights. New HemoShear is discovering new treatments for rare metabolic disorders. We also partner with biopharma companies to accelerate their drug
Keywords N/A
Server Information
WebSite hemoshear faviconhemoshear.com
Host IP 208.75.148.200
Location United States
Related Websites
Site Rank
More to Explore
hemoshear.com Valuation
US$6,121,244
Last updated: 2023-04-29 09:12:48

hemoshear.com has Semrush global rank of 1,729,110. hemoshear.com has an estimated worth of US$ 6,121,244, based on its estimated Ads revenue. hemoshear.com receives approximately 706,298 unique visitors each day. Its web server is located in United States, with IP address 208.75.148.200. According to SiteAdvisor, hemoshear.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$6,121,244
Daily Ads Revenue US$5,651
Monthly Ads Revenue US$169,512
Yearly Ads Revenue US$2,034,137
Daily Unique Visitors 47,087
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
hemoshear.com. A 7199 IP: 208.75.148.200
hemoshear.com. NS 43200 NS Record: ns1.mytechtailor.com.
hemoshear.com. NS 43200 NS Record: ns2.mytechtailor.com.
hemoshear.com. MX 43200 MX Record: 10 alt3.aspmx.l.google.com.
hemoshear.com. MX 43200 MX Record: 10 alt4.aspmx.l.google.com.
hemoshear.com. MX 43200 MX Record: 1 aspmx.l.google.com.
hemoshear.com. MX 43200 MX Record: 5 alt1.aspmx.l.google.com.
hemoshear.com. MX 43200 MX Record: 5 alt2.aspmx.l.google.com.
hemoshear.com. TXT 43200 TXT Record: v=spf1 +a +mx +ip4:208.75.148.200 +include:_spf.google.com ~all
HtmlToTextCheckTime:2023-04-29 09:12:48
Company HST5040 Patients Pipeline Platform News Careers New Insights. New Hope. HemoShear Therapeutics is a clinical stage company developing novel treatments for patients with rare diseases. We are implementing a new vision for how advanced biological and computational models can accelerate the discovery of innovative therapies to change the course of disease. News: Brian Wamhoff, PhD named interim CEO Read More » Developing Treatments for Rare Diseases Using our powerful REVEAL-Tx TM drug discovery platform, our scientists are identifying and validating promising approaches to develop novel treatments aiming to extend and improve the quality of life of patients with rare diseases. In our most advanced program, the company is conducting a phase 2 clinical trial of HST5040, an oral small molecule investigational drug for the treatment of patients with methylmalonic acidemia (MMA) and propionic acidemia (PA). These genetic disorders are caused by deficiencies of certain metabolic
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Fri, 22 Oct 2021 08:18:36 GMT
Server: Apache
Location: https://hemoshear.com/
Cache-Control: max-age=0
Expires: Fri, 22 Oct 2021 08:18:36 GMT
Content-Type: text/html; charset=iso-8859-1

HTTP/2 200 
x-frame-options: deny
x-xss-protection: 1; mode=block
x-content-type-options: nosniff
cache-control: max-age=0
expires: Fri, 22 Oct 2021 08:18:37 GMT
x-content-type-options: nosniff
content-type: text/html; charset=UTF-8
date: Fri, 22 Oct 2021 08:18:37 GMT
server: Apache
hemoshear.com Whois Information
Domain Name: HEMOSHEAR.COM
Registry Domain ID: 1386690815_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.enom.com
Registrar URL: http://www.enomdomains.com
Updated Date: 2020-01-14T19:59:53Z
Creation Date: 2008-01-24T14:01:06Z
Registry Expiry Date: 2023-01-24T14:01:06Z
Registrar: eNom, LLC
Registrar IANA ID: 48
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.MYTECHTAILOR.COM
Name Server: NS2.MYTECHTAILOR.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-10T23:55:23Z <<<